Table 3:

Factors predicting postfracture care^*

Factor	Care received

	Bone mineral density testing		Pharmacologic treatment		Testing or treatment

	OR (95% CI)	p value	OR (95% CI)	p value	OR (95% CI)	p value
Intervention group

Usual care (reference)	1.00		1.00		1.00

Physician notification	4.73 (3.49–6.40)	< 0.001	1.53 (1.22–1.92)	< 0.001	2.45 (2.01–2.98)	< 0.001

Patient and physician notification	5.50 (4.08–7.42)	< 0.001	1.77 (1.42–2.21)	< 0.001	2.82 (2.33–3.43)	< 0.001

Male sex	0.45 (0.36–0.57)	< 0.001	0.46 (0.37–0.57)	< 0.001	0.45 (0.38–0.53)	< 0.001

Age group, yr

50–59 (reference)	1.00		1.00		1.00

60–69	1.69 (1.31–2.18)	< 0.001	1.41 (1.05–1.89)	0.02	1.47 (1.18–1.83)	< 0.001

70–79	1.33 (1.02–1.74)	0.04	2.34 (1.78–3.07)	< 0.001	1.70 (1.37–2.12)	< 0.001

≥ 80	0.64 (0.48–0.86)	0.003	1.68 (1.28–2.20)	< 0.001	1.09 (0.88–1.35)	0.43

Fracture site

Forearm (reference)	1.00		1.00		1.00

Hip	0.65 (0.49–0.87)	0.004	1.26 (0.97–1.64)	0.09	0.82 (0.66–1.03)	0.09

Humerus	0.72 (0.57–0.90)	0.004	1.04 (0.81–1.32)	0.78	0.85 (0.71–1.03)	0.10

Spine	0.62 (0.45–0.85)	0.003	2.51 (1.93–3.28)	< 0.001	1.50 (1.20–1.88)	< 0.001